乳腺癌心脏保护放疗:基线心脏风险的重要性
结果显示基线CVD风险因素对10年累积CVD风险影响显著,糖尿病患者的基线风险明显更高;吸烟是可改变的重要基线风险因素。系统评估和筛查有助于识别高危患者,使其从一级预防中获益,其获益可能甚至高于单独使用心脏保护照射技术。
要点
- 基线CVD风险因素对10年累积CVD风险有强烈影响。
- 糖尿病患者基线CVD风险显著高于非糖尿病患者。
- 吸烟是最重要且可改变的基线风险因素之一。
核心结论
- 基线CVD风险因素对10年累积CVD风险有强烈影响。
- 系统评估和筛查有助于识别高危患者,使其从一级预防中获益,其获益可能甚至高于单独使用心脏保护照射技术。
研究设计与样本
- 应用Procam、Framingham和Reynolds评分评估个体CVD风险谱,并基于自由呼吸(FB)和DIBH治疗计划的平均心脏剂量(MHD)估算10年CVD超额绝对风险(EAR)。
主要发现
- 非糖尿病队列(n=200)平均基线风险范围为3.11%至3.58%,取决于风险估算工具。
- 大量非糖尿病患者10年CVD基线风险≤1%,但8-9%的患者基线10年CVD风险≥10%。
- 糖尿病患者(n=10)基线CVD风险显著更高(范围:11.76%-24.23%)。
- DIBH技术(MHD:1.42Gy)放疗后10年累积风险(Framingham评分)为3.73%,FB(MHD:2.33Gy)为3.94%,分别对应基线风险增加10年EAR +0.34%(DIBH)和+0.55%(FB)。
- DIBH-RT后,182例非吸烟患者平均10年累积风险为3.55%(基线风险3.20%,EAR 0.35%),而28例吸烟者为6.07%(基线风险5.60%,EAR 0.47%)。
临床怎么用
- 所有CVD预测工具结果可比,可容易地整合到日常临床实践中。
- 系统评估和筛查有助于识别高危患者,使其从一级预防中获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with left-sided breast cancer have an increased risk of cardiovascular disease (CVD) after radiotherapy (RT). While the awareness of cardiac toxicity has increased enormously over the last decade, the role of individual baseline cardiac risks has not yet been systematically investigated. Aim of the present study was to evaluate the impact of baseline CVD risks on radiation-induced cardiac toxicity. METHODS: Two hundred ten patients with left-sided breast cancer treated in the prospective Save-Heart Study using a deep inspiration breath-hold (DIBH) technique were analysed regarding baseline risk factors for CVD. Three frequently used prediction tools (Procam, Framingham and Reynolds score) were applied to evaluate the individual CVD risk profiles. Moreover, 10-year CVD excess absolute risks (EAR) were estimated using the individual mean heart dose (MHD) of treatment plans in free breathing (FB) and DIBH. RESULTS: The individual baseline CVD risk factors had a strong impact on the 10-year cumulative CVD risk. The mean baseline risks of the non-diabetic cohort (n = 200) ranged from 3.11 to 3.58%, depending on the risk estimation tool. A large number of the non-diabetic patients had a very low 10-year CVD baseline risk of ≤1%; nevertheless, 8-9% of patients reached ≥10% baseline 10-year CVD risk. In contrast, diabetic patients (n = 10) had significantly higher baseline CVD risks (range: 11.76-24.23%). The mean 10-year cumulative risk (Framingham score) following RT was 3.73% using the DIBH-technique (MHD:1.42Gy) and 3.94% in FB (MHD:2.33Gy), after adding a 10-year-EAR of + 0.34%(DIBH) and + 0.55%(FB) to the baseline risks, respectively. Smoking status was one of the most important and modifiable baseline risk factors. After DIBH-RT, the 182 non-smoking patients had a mean 10-year cumulative risk of 3.55% (3.20% baseline risk, 0.35% EAR) as compared to 6.07% (5.60% baseline risk, 0.47% EAR) for the 28 smokers. CONCLUSION: In the present study, all CVD prediction tools showed comparable results and could easily be integrated into daily clinical practice. A systematic evaluation and screening helps to identify high-risk patients who may benefit from primary prevention. This could result in an even higher benefit than from heart-sparing irradiation techniques alone.
引用
- Gaasch A, Schönecker S, Simonetto C, et al. Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks. Radiat Oncol. 2020. PMID: 32448164. doi:10.1186/s13014-020-01520-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。